$AVNS

Shimer Julie Ann sold (to issuer) $1.3M of AVNS

Shimer Julie Ann sold (to issuer) 50,090 shares of AVANOS MEDICAL, INC. (AVNS) at $25.00 ($1.25M total) on 2026-07-27.

Original reporting
SEC EDGAR · Shimer Julie Ann
Published Jul 28, 2026, 9:38 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 9:40 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AVNS
Neutral
medium confidence
Mentioned
$AVNS
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AVNSNeutralLow
01

Why it matters

The newest disclosed fact is the director’s sale to the issuer: 50,090 shares at $25.00/share, leaving 0 shares after the transaction.

02

Market read

Traders may note insider selling activity, but there is no new guidance, contract, litigation, or operational datapoint to reprice the business.

03

What to watch

No 10b5-1 plan is indicated, which can increase interpretive noise, but the filing still lacks any accompanying narrative about business outlook or risk.

Relevance 6/10Novelty 3/10Timing: filed after-hours on 2026-07-28, covering a 2026-07-27 sale

Background

The article is an SEC Form 4 insider transaction for AVANOS MEDICAL, INC. (AVNS) by a director.

Company-level read

Ticker impact

$AVNSNeutralMedium confidence
Context

Director Shimer Julie Ann sold 50,090 shares to the issuer on 2026-07-27 at $25.00/share, totaling $1.25M.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only and typically fades.

Evidence & confidence

Form 4 insider transactions are common and this filing provides no new operational, financial, or regulatory information beyond the sale mechanics and price.

Market effects

None; this is company-specific insider transaction data.

None.

None.

Counterpoint

The sale could be non-informational (tax planning or liquidity) and the “to issuer” structure can reflect standardized buyback participation rather than bearish signaling.

Key entities

  • AVANOS MEDICAL, INC.

    Company whose director insider sale is disclosed on Form 4.

  • Shimer Julie Ann

    Director who sold shares to the issuer on 2026-07-27.

Related articles

$AVNSLow

AVANOS MEDICAL, INC. (AVNS): Completion of Acquisition or Disposition of Assets

AVANOS MEDICAL, INC. (AVNS) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-10.1 4 avnsform8k_07272026xex101.htm EX-10.1 Document Execution Version CREDIT AGREEMENT dated as of July 27, 2026 among A-AV MERGERSUB, INC., as the Initial Borrower, AVANOS MEDICAL, INC., as the Borrower Representative, A-AV ACQUIRECO, INC., as a Borrower, A-AV INTERMEDIATEC